Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity

Detalhes bibliográficos
Autor(a) principal: Santos, Karolina Torres
Data de Publicação: 2019
Outros Autores: Silva, Fabricio Ocampo da Luz e, Schneider, Leandro Alves, Santos, Carlos Eduardo Rangel dos, Silva, Sue Elle Berro da, Fernandes, Maquelen Blanco, Rocha, Leandro, Oliveira, Luís Flávio Souza de, Machado, Michel Mansur, Moreira, Cleci Menezes
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/164717
Resumo: The essential oil of the leaves of Eugenia sulcata, in the Myrtaceae family, has a demonstrated antihypertensive effect, but its effects on heart muscle and its toxicity have not yet been elucidated. Little chemical or biological data are available for E. sulcata, whether emphasizing the beneficial effects or the pharmacological security of this species. This study aims to evaluate myocardial contractility and to analyze angiotensin converting enzyme (ACE) and myosin ATPase activities associated with use of this essential oil. In addition, we evaluated the immunotoxicity of E. sulcata essential oil. Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR) were treated daily for 30 days (10 mg/kg of oil) to evaluate the isometric force of the papillary muscle, ACE measured by fluorimetry, and myosin ATPase activities by inorganic phosphate. Lymphocyte cultures were used to evaluate cytotoxicity, DNA damage, and mutagenicity of the essential oil. The results demonstrate that the treatment did not change the cardiac contraction force and did not alter the functioning of the sarcoplasmic reticulum, extrusion of the membrane calcium, or modify the membrane calcium channels or β-adrenergic receptor activity. Tetanic contractions were potentiated in the SHR animals. Myosin ATPase activity was also increased in the SHR animals. Cardiac ACE activity was reduced in both animal strains, and the serum ACE was reduced only in the SHR animals. The essential oil did not cause cytotoxicity or mutagenicity and presented low DNA damage. Our results demonstrated that the essential oil does not change myocardial contractility and does not present relevant immunotoxicity.
id USP-31_e67b1558a6d65cd55de28597945b771d
oai_identifier_str oai:revistas.usp.br:article/164717
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicityMyrtaceae/adverse effectsAngiotensin-Converting Enzyme Inhibitors/immunologyThe essential oil of the leaves of Eugenia sulcata, in the Myrtaceae family, has a demonstrated antihypertensive effect, but its effects on heart muscle and its toxicity have not yet been elucidated. Little chemical or biological data are available for E. sulcata, whether emphasizing the beneficial effects or the pharmacological security of this species. This study aims to evaluate myocardial contractility and to analyze angiotensin converting enzyme (ACE) and myosin ATPase activities associated with use of this essential oil. In addition, we evaluated the immunotoxicity of E. sulcata essential oil. Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR) were treated daily for 30 days (10 mg/kg of oil) to evaluate the isometric force of the papillary muscle, ACE measured by fluorimetry, and myosin ATPase activities by inorganic phosphate. Lymphocyte cultures were used to evaluate cytotoxicity, DNA damage, and mutagenicity of the essential oil. The results demonstrate that the treatment did not change the cardiac contraction force and did not alter the functioning of the sarcoplasmic reticulum, extrusion of the membrane calcium, or modify the membrane calcium channels or β-adrenergic receptor activity. Tetanic contractions were potentiated in the SHR animals. Myosin ATPase activity was also increased in the SHR animals. Cardiac ACE activity was reduced in both animal strains, and the serum ACE was reduced only in the SHR animals. The essential oil did not cause cytotoxicity or mutagenicity and presented low DNA damage. Our results demonstrated that the essential oil does not change myocardial contractility and does not present relevant immunotoxicity.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2019-12-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/16471710.1590/s2175-97902019000117742Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17742Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e17742Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e177422175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/164717/157928Copyright (c) 2019 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSantos, Karolina TorresSilva, Fabricio Ocampo da Luz eSchneider, Leandro AlvesSantos, Carlos Eduardo Rangel dosSilva, Sue Elle Berro daFernandes, Maquelen BlancoRocha, LeandroOliveira, Luís Flávio Souza deMachado, Michel MansurMoreira, Cleci Menezes2021-01-11T18:07:52Zoai:revistas.usp.br:article/164717Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-01-11T18:07:52Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity
title Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity
spellingShingle Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity
Santos, Karolina Torres
Myrtaceae/adverse effects
Angiotensin-Converting Enzyme Inhibitors/immunology
title_short Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity
title_full Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity
title_fullStr Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity
title_full_unstemmed Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity
title_sort Essential oil of the leaves of Eugenia sulcata preserve myocardial contractility and does not present immunotoxicity
author Santos, Karolina Torres
author_facet Santos, Karolina Torres
Silva, Fabricio Ocampo da Luz e
Schneider, Leandro Alves
Santos, Carlos Eduardo Rangel dos
Silva, Sue Elle Berro da
Fernandes, Maquelen Blanco
Rocha, Leandro
Oliveira, Luís Flávio Souza de
Machado, Michel Mansur
Moreira, Cleci Menezes
author_role author
author2 Silva, Fabricio Ocampo da Luz e
Schneider, Leandro Alves
Santos, Carlos Eduardo Rangel dos
Silva, Sue Elle Berro da
Fernandes, Maquelen Blanco
Rocha, Leandro
Oliveira, Luís Flávio Souza de
Machado, Michel Mansur
Moreira, Cleci Menezes
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Santos, Karolina Torres
Silva, Fabricio Ocampo da Luz e
Schneider, Leandro Alves
Santos, Carlos Eduardo Rangel dos
Silva, Sue Elle Berro da
Fernandes, Maquelen Blanco
Rocha, Leandro
Oliveira, Luís Flávio Souza de
Machado, Michel Mansur
Moreira, Cleci Menezes
dc.subject.por.fl_str_mv Myrtaceae/adverse effects
Angiotensin-Converting Enzyme Inhibitors/immunology
topic Myrtaceae/adverse effects
Angiotensin-Converting Enzyme Inhibitors/immunology
description The essential oil of the leaves of Eugenia sulcata, in the Myrtaceae family, has a demonstrated antihypertensive effect, but its effects on heart muscle and its toxicity have not yet been elucidated. Little chemical or biological data are available for E. sulcata, whether emphasizing the beneficial effects or the pharmacological security of this species. This study aims to evaluate myocardial contractility and to analyze angiotensin converting enzyme (ACE) and myosin ATPase activities associated with use of this essential oil. In addition, we evaluated the immunotoxicity of E. sulcata essential oil. Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR) were treated daily for 30 days (10 mg/kg of oil) to evaluate the isometric force of the papillary muscle, ACE measured by fluorimetry, and myosin ATPase activities by inorganic phosphate. Lymphocyte cultures were used to evaluate cytotoxicity, DNA damage, and mutagenicity of the essential oil. The results demonstrate that the treatment did not change the cardiac contraction force and did not alter the functioning of the sarcoplasmic reticulum, extrusion of the membrane calcium, or modify the membrane calcium channels or β-adrenergic receptor activity. Tetanic contractions were potentiated in the SHR animals. Myosin ATPase activity was also increased in the SHR animals. Cardiac ACE activity was reduced in both animal strains, and the serum ACE was reduced only in the SHR animals. The essential oil did not cause cytotoxicity or mutagenicity and presented low DNA damage. Our results demonstrated that the essential oil does not change myocardial contractility and does not present relevant immunotoxicity.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-02
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/164717
10.1590/s2175-97902019000117742
url https://www.revistas.usp.br/bjps/article/view/164717
identifier_str_mv 10.1590/s2175-97902019000117742
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/164717/157928
dc.rights.driver.fl_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17742
Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e17742
Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17742
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222914467856384